8-K
filed June 4, 2025, 7:59 PM ET
ticker AMPH
CIK 0001297184
other
confidence high
sentiment neutral
materiality 0.25
Stockholders approve charter amendments for officer exculpation and forum selection removal at annual meeting
Amphastar Pharmaceuticals, Inc.
- Elected three Class III directors: Jack Y. Zhang, Richard Prins, Diane G. Gerst (each with majority support).
- Approved charter amendment for officer exculpation under Delaware law (35.5M for, 2.9M against).
- Approved removal of forum selection provision from charter (37.4M for, 52k against).
- Ratified Ernst & Young as independent auditor for fiscal 2025 (41.5M for).
- Bylaws amended to specify Delaware Court of Chancery as exclusive forum for certain internal actions.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Amphastar Pharmaceuticals, Inc.: Approved amendment to Bylaws to clarify exclusive forum selection for certain legal actions (effective 2025-06-02).
- Change
- bylaw amendment
- Effective
- 2025-06-02
Exact text from the filing
the board of directors of the Company approved an amendment to the amended and restated bylaws of the Company (the “Bylaws” and such amendment, the "Bylaws Amendment”) clarifying that unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or the United States District Court for the District of Delaware) and any appellate court therefrom will be the sole and exclusive forum
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Amphastar Pharmaceuticals, Inc.: Approved amendment to Charter to include officer exculpation provisions under Delaware law (effective 2025-06-02).
- Change
- charter amendment
- Effective
- 2025-06-02
Exact text from the filing
the stockholders of the Company voted on and approved amendments to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) (i) to reflect Delaware law provisions regarding officer exculpation (the “Exculpation Amendment”);
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Amphastar Pharmaceuticals, Inc.: Approved amendment to Charter to remove forum selection provision (effective 2025-06-02).
- Change
- charter amendment
- Effective
- 2025-06-02
Exact text from the filing
and (ii) to remove the forum selection provision (the “Forum Selection Amendment,” and together with the Exculpation Amendment, the “Charter Amendments”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.